Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Do you avoid adding high energy photons (with associated neutrons) for younger breast cancer patients, out of concern for secondary malignancy risk?
Answer from: Radiation Oncologist at Community Practice
We used mixed, whenever appropriate, with optimization of dose distribution using field within field technique (no wedges).
Sign in or Register to read more
9244
Related Questions
Would you recommend PMRT to a clinically node positive (biopsy proven axillary node and indeterminate single IMN node) BRCA positive patient with multiple medical co-morbidities including scleroderma and ILD who is treated with neoadjuvant chemotherapy (NAC) and mastectomy who converts to ypT0/ypN0?
Is it appropriate to use bolus with hypofractionated PMRT?
Does the presence of LCIS on pathology in a patient with IDC impact your decision to offer APBI?
How are you clinically incorporating the data presented from RT Charm at ASTRO 2024?
When treating APBI with the Florence regimen, are you using daily or every other day fractionation?
When should the dissected axilla (levels I-II) be included when delivering RNI?
For patients between 40-49 years old who undergo lumpectomy, how do you choose between offering PBI per the updated PBI guidelines or boosting based on boost guidelines?
Are there additional risks associated with PMRT for a patient with prior lympho-venous bypass surgery?
Would you omit radiation for an elderly woman with bilateral breast cancers (both early-stage disease and ER+/PR+/HER2 negative) who otherwise meets the criteria for endocrine therapy alone?
Does your dosimetrist use skin flash for VMAT whole breast or RNI plans?